Back to Journals » Drug Design, Development and Therapy » Volume 9

Review

Brentuximab vedotin for relapsed or refractory Hodgkin’s lymphoma

       
Total article views   HTML views PDF downloads Totals
13,251 Dovepress* 10,587+ 1,895 12,482
PubMed Central* 2,664 731 3,395
Totals 13,251 2,626 15,877
*Since 23 March 2015
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 1 1

View citations on PubMed Central and Google Scholar